InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-9.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Watkins Thomas, Director. Director active across 2 companies, notably Vanda Pharmaceuticals Inc.. Cumulatively, 7 reports have been recorded. History available since 10 June 2021. The latest transaction was filed on 6 October 2023 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
110,447 shares@ US$116.5096.3% of flowOrdinary SharesSEC:0001209191-23-052376:0
40,000 shares@ US$12.293.7% of flowOrdinary SharesSEC:0001209191-23-051234:0
3,913 sharesOrdinary SharesSEC:0001209191-23-026757:0
15,000 shares@ US$4.150.015% mcap100.0% of flowCommon StockSEC:0001209191-22-034062:0
4,223 sharesOrdinary SharesSEC:0001209191-22-026471:0
5,000 shares0Common StockSEC:0001209191-21-040244
5,000 shares0Common StockSEC:0001209191-21-040244:0
7 of 7 declarations
About Watkins Thomas
Thomas Watkins serves as a Board Member at Vanda Pharmaceuticals Inc. and Horizon Therapeutics Public Ltd Co. He plays a key role in the governance of these companies, bringing his expertise in strategy and business development. His experience in the pharmaceutical sector enables him to effectively contribute to discussions on innovation and regulation. As a board member, he is responsible for overseeing operations and strategic direction, ensuring that these companies adhere to compliance and ethical standards.
